Trial Profile
The Effects of Human Umbilical Cord Mesenchymal Stem Cell Therapy on Neurological Function for Cerebral Infarction Patients in Convalescent Period
Status:
Suspended
Phase of Trial:
Phase I/II
Latest Information Update: 23 Apr 2024
Price :
$35
*
At a glance
- Drugs Umbilical cord mesenchymal stem cell therapy Sclnow Biotechnology (Primary) ; Aspirin; Atorvastatin
- Indications Cerebral infarction
- Focus Therapeutic Use
- Sponsors Sclnow Biotechnology
- 18 Apr 2024 Planned End Date changed from 1 Dec 2024 to 31 Dec 2025.
- 18 Apr 2024 Planned primary completion date changed from 1 Jun 2024 to 30 Jun 2025.
- 18 Apr 2024 Planned initiation date changed from 1 Dec 2022 to 31 Dec 2024.